PRESS RELEASE published on 02/09/2024 at 07:16, 2 years 6 months ago EQS-Adhoc: ams OSRAM delivers solid Q4, with revenues and adj. EBIT above the mid-point of the guided range, and continues executing its turnaround plan to benefit from structural growth ams OSRAM delivers solid Q4 results with revenues and adj. EBIT above guided range, progressing with 'Re-establish the Base' plan for structural growth in automotive, industrial, medical, and consumer applications Revenues Q4 Results Ams OSRAM Adj. EBIT Structural Growth
PRESS RELEASE published on 10/31/2023 at 07:00, 2 years 9 months ago EQS-Adhoc: ams-OSRAM AG: ams OSRAM announces Q3 profitability at upper end of the guidance, revenue above mid-point and re-confirms mid-term target financial model on the back of strong automotive design-wins
PRESS RELEASE published on 10/30/2023 at 07:00, 2 years 9 months ago EQS-Adhoc: ams-OSRAM AG: ams OSRAM signs close to EUR 450 million of infrastructure related asset transactions as part of its recently presented financing plan
PRESS RELEASE published on 10/20/2023 at 13:05, 2 years 9 months ago ams-OSRAM AG: ams OSRAM’s Extraordinary General Meeting approves all voting items incl. capital raise to secure a long-term stable financial base for structural growth
PRESS RELEASE published on 09/27/2023 at 18:55, 2 years 10 months ago ams-OSRAM AG: Convocation of the Extraordinary General Meeting 2023
PRESS RELEASE published on 09/27/2023 at 18:50, 2 years 10 months ago EQS-Adhoc: ams-OSRAM AG: ams OSRAM to secure long-term stable financial base for structural growth
PRESS RELEASE published on 09/20/2023 at 12:30, 2 years 10 months ago ams-OSRAM AG: The German federal government and the Free State of Bavaria commit support to ams OSRAM for groundbreaking semiconductor technology
PRESS RELEASE published on 09/11/2023 at 09:36, 2 years 10 months ago ams-OSRAM AG: Malaysian Investment Development Authority (MIDA) and ams OSRAM continue mutual support for advanced LED manufacturing in Malaysia
PRESS RELEASE published on 07/27/2023 at 21:20, 3 years ago EQS-Adhoc: ams-OSRAM AG: ams OSRAM sharpens portfolio towards profitability and structural growth; announces profitability for Q2 at the upper end of guidance
PRESS RELEASE published on 07/21/2023 at 10:20, 3 years ago ams-OSRAM AG: Juergen Rebel is the new Head of Investor Relations at ams OSRAM
Published on 08/10/2026 at 11:00, 17 minutes ago Blue Lagoon Announces C$10 Million Strategic Investment by Nicola Mining and Ocean Partners
Published on 08/10/2026 at 08:00, 3 hours 17 minutes ago Galantas Gold Expands Indiana Drill Program to 12,500 Metres
Published on 08/10/2026 at 08:00, 3 hours 17 minutes ago Results of AGM and Management Update Presentation
Published on 08/07/2026 at 23:15, 2 days 12 hours ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/10/2026 at 10:12, 1 hour 4 minutes ago Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 08/10/2026 at 10:10, 1 hour 6 minutes ago Hana Bank Subsidiary GLN Expands QR Payment Network for International Travelers to Korea
Published on 08/10/2026 at 09:50, 1 hour 27 minutes ago Photon Energy N.V. Bond 21/27 (ISIN: DE000A3KWKY4): Signs of a crisis are mounting. What can investors do? Invitation to video conferences (German/English)
Published on 08/10/2026 at 09:00, 2 hours 16 minutes ago Original-Research: Rosenbauer International AG (von NuWays AG): BUY
Published on 08/10/2026 at 09:47, 1 hour 29 minutes ago 260810 BENETEAU Transactions sur actions propres
Published on 08/10/2026 at 09:22, 1 hour 54 minutes ago Number of shares and voting rights - July 2026 (In French only)
Published on 08/10/2026 at 09:22, 1 hour 54 minutes ago Nombre total d'actions et droits de vote - juillet 2026
Published on 08/10/2026 at 07:00, 4 hours 17 minutes ago BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
Published on 08/10/2026 at 07:00, 4 hours 17 minutes ago Biophytis annonce l’autorisation de l’étude clinique OBA au Brésil et partage les perspectives de BIO101 dans l’obésité
